Biomedical subjects
Publications and source records attributed to Colette Marsan.
Organized screening for cervical carcinoma has already demonstrated its efficiency in industrial countries but it still has to be better organized, particularly in developing countries. In the European Union, results may be improved thanks to more cooperation with Health authorities, enabling the pathologists to focus the risk evaluation and to broadcast recommendations about prevention on a population level.
As healthcare rules are becoming better organized and as vaccination against Human Papillomavirus (HPV) infections is arising, the conditions of cytological screening for cervical carcinoma may have to be modified in the near future. After reminding the Quality Control constraints of the Pap test and the technical and epidemiological conditions for the HPV detection as a precursor of cervical carcinoma, the present paper wishes to discuss the possible role of vaccine on the screening strategy.